Adventris Pharmaceuticals
Overview
Adventris Pharmaceuticals is a biotechnology company specializing in the development of cancer vaccines. Their platform addresses the challenge of targeting poorly immunogenic oncogenes, with a focus on KRAS mutations.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Adventris Pharmaceuticals in our records. PharmaTek screens the full directory against live FDA enforcement data.
Related companies
Alpha Oncology Therapeutics, Inc.
USA
American Cyanamid Company (as Wyeth-Ayerst Laboratories)
United States
Aulos Bioscience, Inc.
United States
Cancer Research Innovations, Inc.
USA
Checkpoint Therapeutics, Inc.
United States
Eureka Therapeutics, Inc.
United States
Fate Therapeutics, Inc.
United States
FHI Clinical, Inc.
United States
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.